Built using insights from the Lyfegen Agreements Library—housing over 7,000 public agreements—this report explores how payers and pharma are tackling today’s biggest challenges, from cost-effectiveness barriers to innovative reimbursement strategies.
Reimbursing Beyond Cost-Effectiveness
Learn how payers are enabling access to high-cost therapies despite traditional cost barriers—driven by unmet needs, severity of disease, orphan designations, and patient advocacy.
Latest Agreements and Trends
Gain real-world insights from 339 newly identified agreements across 30 countries. See the growing impact of outcome guarantees, budget caps, installment payments, and restricted access models.
Regional Perspectives
Explore developments across Europe, Latin America, the Nordics, Australia, and more—highlighting how local regulations and payer strategies are evolving in 2025.
Strategic Takeaways for Pharma
Understand how manufacturers can navigate today’s access environment by:
✔️ Building multi-dimensional value arguments
✔️ Preparing for risk-sharing negotiations
✔️ Leveraging real-world evidence (RWE)
✔️ Targeting optimal patient subgroups
* By sending this message, you agree to our privacy policy.
Sign up & be the first to know about INNOVATIONS
* By sending this message, you agree to our privacy policy.
